Format
Items per page
Sort by

Send to:

Choose Destination

Results: 19

1.

Combined angiotensin inhibition for the treatment of diabetic nephropathy.

Fried LF, Emanuele N, Zhang JH, Brophy M, Conner TA, Duckworth W, Leehey DJ, McCullough PA, O'Connor T, Palevsky PM, Reilly RF, Seliger SL, Warren SR, Watnick S, Peduzzi P, Guarino P; VA NEPHRON-D Investigators.

N Engl J Med. 2013 Nov 14;369(20):1892-903. doi: 10.1056/NEJMoa1303154. Epub 2013 Nov 9. Erratum in: N Engl J Med. 2014;158:A7255.

2.

Effects of 6-times-weekly versus 3-times-weekly hemodialysis on depressive symptoms and self-reported mental health: Frequent Hemodialysis Network (FHN) Trials.

Unruh ML, Larive B, Chertow GM, Eggers PW, Garg AX, Gassman J, Tarallo M, Finkelstein FO, Kimmel PL; FHN Trials Group.

Am J Kidney Dis. 2013 May;61(5):748-58. doi: 10.1053/j.ajkd.2012.11.047. Epub 2013 Jan 15.

PMID:
23332990
3.

Challenges to enrollment and randomization of the Frequent Hemodialysis Network (FHN) Daily Trial.

Sergeyeva O, Gorodetskaya I, Ramos R, Schiller BM, Larive B, Raimann JG, Ting GO, Eggers PW, Chertow GM, Levin NW; Frequent Hemodialysis Network Trials Group.

J Nephrol. 2012 May-Jun;25(3):302-9. doi: 10.5301/jn.5000160.

PMID:
22505248
4.

The effect of frequent hemodialysis on nutrition and body composition: frequent Hemodialysis Network Trial.

Kaysen GA, Greene T, Larive B, Mehta RL, Lindsay RM, Depner TA, Hall YN, Daugirdas JT, Chertow GM; FHN Trial Group.

Kidney Int. 2012 Jul;82(1):90-9. doi: 10.1038/ki.2012.75. Epub 2012 Mar 28.

5.

Effects of six versus three times per week hemodialysis on physical performance, health, and functioning: Frequent Hemodialysis Network (FHN) randomized trials.

Hall YN, Larive B, Painter P, Kaysen GA, Lindsay RM, Nissenson AR, Unruh ML, Rocco MV, Chertow GM; Frequent Hemodialysis Network Trial Group.

Clin J Am Soc Nephrol. 2012 May;7(5):782-94. doi: 10.2215/CJN.10601011. Epub 2012 Mar 15.

6.

Relationship of estimated GFR and coronary artery calcification in the CRIC (Chronic Renal Insufficiency Cohort) Study.

Budoff MJ, Rader DJ, Reilly MP, Mohler ER 3rd, Lash J, Yang W, Rosen L, Glenn M, Teal V, Feldman HI; CRIC Study Investigators.

Am J Kidney Dis. 2011 Oct;58(4):519-26. doi: 10.1053/j.ajkd.2011.04.024. Epub 2011 Jul 23.

7.

Baseline physical performance, health, and functioning of participants in the Frequent Hemodialysis Network (FHN) trial.

Kaysen GA, Larive B, Painter P, Craig A, Lindsay RM, Rocco MV, Daugirdas JT, Schulman G, Chertow GM; FHN Trial Group.

Am J Kidney Dis. 2011 Jan;57(1):101-12. doi: 10.1053/j.ajkd.2010.08.021.

8.

Baseline characteristics of participants in the Frequent Hemodialysis Network (FHN) daily and nocturnal trials.

Rocco MV, Larive B, Eggers PW, Beck GJ, Chertow GM, Levin NW, Kliger AS; FHN Trial Group.

Am J Kidney Dis. 2011 Jan;57(1):90-100. doi: 10.1053/j.ajkd.2010.08.024. Epub 2010 Nov 30.

9.

In-center hemodialysis six times per week versus three times per week.

FHN Trial Group, Chertow GM, Levin NW, Beck GJ, Depner TA, Eggers PW, Gassman JJ, Gorodetskaya I, Greene T, James S, Larive B, Lindsay RM, Mehta RL, Miller B, Ornt DB, Rajagopalan S, Rastogi A, Rocco MV, Schiller B, Sergeyeva O, Schulman G, Ting GO, Unruh ML, Star RA, Kliger AS.

N Engl J Med. 2010 Dec 9;363(24):2287-300. doi: 10.1056/NEJMoa1001593. Epub 2010 Nov 20. Erratum in: N Engl J Med. 2011 Jan 6;364(1):93.

10.

Chronic kidney disease and cognitive function in older adults: findings from the chronic renal insufficiency cohort cognitive study.

Yaffe K, Ackerson L, Kurella Tamura M, Le Blanc P, Kusek JW, Sehgal AR, Cohen D, Anderson C, Appel L, Desalvo K, Ojo A, Seliger S, Robinson N, Makos G, Go AS; Chronic Renal Insufficiency Cohort Investigators.

J Am Geriatr Soc. 2010 Feb;58(2):338-45. doi: 10.1111/j.1532-5415.2009.02670.x. Epub 2010 Jan 26.

11.

Solute clearances and fluid removal in the frequent hemodialysis network trials.

Greene T, Daugirdas JT, Depner TA, Gotch F, Kuhlman M; Frequent Hemodialysis Network Study Group; National Institute of Diabetes and Digestive and Kidney Diseases; National Institutes of Health.

Am J Kidney Dis. 2009 May;53(5):835-44. doi: 10.1053/j.ajkd.2008.12.039. Epub 2009 Apr 1.

PMID:
19339093
12.

Ring-expansion metathesis polymerization: catalyst-dependent polymerization profiles.

Xia Y, Boydston AJ, Yao Y, Kornfield JA, Gorodetskaya IA, Spiess HW, Grubbs RH.

J Am Chem Soc. 2009 Feb 25;131(7):2670-7. doi: 10.1021/ja808296a.

13.

Cyclic ruthenium-alkylidene catalysts for ring-expansion metathesis polymerization.

Boydston AJ, Xia Y, Kornfield JA, Gorodetskaya IA, Grubbs RH.

J Am Chem Soc. 2008 Sep 24;130(38):12775-82. doi: 10.1021/ja8037849. Epub 2008 Aug 27.

14.

Hyperbranched macromolecules via olefin metathesis.

Gorodetskaya IA, Choi TL, Grubbs RH.

J Am Chem Soc. 2007 Oct 24;129(42):12672-3. Epub 2007 Sep 29. No abstract available.

PMID:
17902678
15.

Health-related quality of life and estimates of utility in chronic kidney disease.

Gorodetskaya I, Zenios S, McCulloch CE, Bostrom A, Hsu CY, Bindman AB, Go AS, Chertow GM.

Kidney Int. 2005 Dec;68(6):2801-8.

PMID:
16316356
16.
17.

Role of thyroid hormones in stress-induced synthesis of heat-shock proteins in the myocardium.

Gorodetskaya IV, Bozhko AP, Bakhtina LY, Malyshev IY.

Bull Exp Biol Med. 2000 Dec;130(12):1138-40.

PMID:
11276303
18.

Issues in renal nutrition for persons from the former Soviet Union.

Gorodetskaya I, Matel J, Chertow GM.

J Ren Nutr. 2000 Apr;10(2):98-102. Review.

PMID:
10757823
19.

Influence of the thyroid status of the organism in the realization of the adaptational effect of cold.

Bozhko AP, Gorodetskaya IV.

Neurosci Behav Physiol. 1995 Jul-Aug;25(4):311-8.

PMID:
8570038
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk